CABOT CORP (CBT) Forecast, Price Target & Analyst Ratings

NYSE:CBTUS1270551013

Current stock price

67.93 USD
-1.05 (-1.52%)
At close:
67.93 USD
0 (0%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CABOT CORP (CBT).

Forecast Snapshot

Consensus Price Target

Price Target
$78.03
+ 14.87% Upside

Next Earnings Forecast

Earnings Estimate
Release Date
May 4, 2026
Period
Q2 / 2026
EPS Estimate
$1.48
Revenue Estimate
909.78M

ChartMill Buy Consensus

Rating
51.67%
Weighted Analyst Rating Score

Price Target Details & History

Consensus Price Target and Range

Mean target
$78.03
Upside
+ 14.87%
From current price of $67.93 to mean target of $78.03, Based on 12 analyst forecasts
Low
$65.65
Median
$79.56
High
$89.25

Price Target Revisions

1 Month
8.05%
3 Months
14.18%

Price Target Summary

12 Wall Street analysts provided a forecast for the next 12 months for CBT. The average price target is 78.03 USD. This implies a price increase of 14.87% is expected in the next year compared to the current price of 67.93.
The average price target has been revised upward by 14.18% in the past 3 months.

Analyst Ratings & History

Current Analyst Ratings

CBT Current Analyst RatingCBT Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4

Analyst Ratings History

CBT Historical Analyst RatingsCBT Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
51.67%
CBT was analyzed by 12 analysts. The buy percentage consensus is at 52. So analysts seem to be rather neutral about CBT.
In the last month the buy percentage fell by 21 points. So the trust of analysts is decreasing.
CBT was analyzed by 12 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-02-05MizuhoDowngrade Outperform -> Neutral
2026-02-05UBSMaintains Neutral -> Neutral
2026-01-12UBSMaintains Neutral -> Neutral
2025-12-18MizuhoMaintains Outperform -> Outperform
2025-11-28JP MorganMaintains Underweight -> Underweight
2025-11-17MizuhoMaintains Outperform -> Outperform
2025-11-05UBSMaintains Neutral -> Neutral
2025-10-03MizuhoMaintains Outperform -> Outperform
2025-08-05UBSMaintains Neutral -> Neutral
2025-04-07UBSMaintains Neutral -> Neutral
2025-02-21JP MorganMaintains Underweight -> Underweight
2025-01-07MizuhoMaintains Outperform -> Outperform
2024-11-11JP MorganDowngrade Neutral -> Underweight
2024-11-05MizuhoMaintains Outperform -> Outperform
2024-08-07JP MorganMaintains Neutral -> Neutral
2024-08-06UBSMaintains Neutral -> Neutral
2024-05-07MizuhoMaintains Buy -> Buy
2024-05-07UBSMaintains Neutral -> Neutral
2024-04-18Deutsche BankDowngrade Buy -> Hold
2024-03-27MizuhoInitiate Buy
2024-01-08UBSDowngrade Buy -> Neutral
2023-12-14UBSMaintains Buy -> Buy
2023-11-07UBSMaintains Buy -> Buy
2023-08-11JP MorganMaintains Neutral -> Neutral
2023-08-08Credit SuisseMaintains Outperform -> Outperform

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 4, 2026
Period
Q2 / 2026
EPS Estimate
$1.48
Revenue Estimate
909.78M
Revenue Q2Q
-2.80%
EPS Q2Q
-22.16%
Number of Analysts
6

Next Earnings Revisions

Revenue (1 Month)
1.01%
Revenue (3 Months)
-1.02%
EPS (1 Month)
-2.53%
EPS (3 Months)
-12.16%

Next Earnings Summary

CBT is expected to report earnings on 5/4/2026. The consensus EPS estimate for the next earnings is 1.48 USD and the consensus revenue estimate is 909.78M USD.
The next earnings revenue estimate has been revised downward by 1.02% in the past 3 months.

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029
Revenue
YoY % growth
CBT revenue by date.CBT revenue by date.
3.931B
-9.03%
3.994B
1.60%
3.713B
-7.04%
3.599B
-3.07%
3.703B
2.89%
3.836B
3.59%
4.116B
7.30%
EBITDA
YoY % growth
CBT ebitda by date.CBT ebitda by date.
673M
-6.27%
765M
13.67%
775M
1.31%
738.06M
-4.77%
782.08M
5.96%
826.3M
5.65%
N/A
EBIT
YoY % growth
CBT ebit by date.CBT ebit by date.
529M
-7.52%
614M
16.07%
621M
1.14%
567.4M
-8.63%
605.38M
6.69%
643.29M
6.26%
727.2M
13.04%
Operating Margin
CBT operating margin by date.CBT operating margin by date.
13.46%15.37%16.73%15.77%16.35%16.77%17.67%
EPS
YoY % growth
CBT eps by date.CBT eps by date.
5.38
-14.06%
7.06
31.23%
7.26
2.83%
6.33
-12.86%
7.02
10.97%
7.71
9.76%
8.79
14.03%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27 Q1 / 28 Q2 / 28 Q3 / 28 Q4 / 28
EPS
Q2Q % growth
1.48
-22.16%
1.65
-12.97%
1.71
0.48%
1.64
7.11%
1.91
29.23%
1.87
13.15%
1.83
7.02%
1.60
-2.62%
1.95
1.98%
2.04
9.04%
1.90
3.87%
Revenue
Q2Q % growth
909.78M
-2.80%
914.01M
-0.97%
882.22M
-1.87%
893.85M
5.28%
981.53M
7.89%
962.2M
5.27%
934.93M
5.97%
914.99M
2.37%
1.005B
2.39%
985.02M
2.37%
957.07M
2.37%
EBITDA
Q2Q % growth
174.61M
-26.32%
189.89M
-32.42%
188M
-35.40%
190.03M
11.78%
207.38M
18.77%
205.14M
8.03%
199.85M
6.30%
189.82M
-0.11%
213.62M
3.01%
218.05M
6.29%
207.19M
3.67%
EBIT
Q2Q % growth
132.06M
-18.48%
147.24M
-11.83%
145.36M
6.10%
136.56M
5.86%
159.01M
20.41%
163.2M
10.84%
151.93M
4.52%
144.47M
5.79%
168.27M
5.82%
172.7M
5.82%
161.84M
6.52%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

CBT Yearly Revenue VS EstimatesCBT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1B 2B 3B 4B
CBT Yearly EPS VS EstimatesCBT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6 8

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
2.01%
EPS Next 5 Year
4.89%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
0.24%
Revenue Next 5 Year
1.96%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
7.02%
EBIT Next 5 Year
N/A

CABOT CORP / CBT Forecast FAQ

What is the average price target for CABOT CORP (CBT) stock?

12 analysts have analysed CBT and the average price target is 78.03 USD. This implies a price increase of 14.87% is expected in the next year compared to the current price of 67.93.

When does CABOT CORP (CBT) report earnings?

CABOT CORP (CBT) will report earnings on 2026-05-04, after the market close.

Can you provide the consensus estimates for CABOT CORP next earnings?

The consensus EPS estimate for the next earnings of CABOT CORP (CBT) is 1.48 USD and the consensus revenue estimate is 909.78M USD.

What is the expected long term growth rate for CABOT CORP (CBT)?

The expected long term growth rate for CABOT CORP (CBT) is 0.24%.